Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma of the Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Testing effectiveness (Phase 2)UnknownNCT04395612
What this trial is testing

Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 38
Not applicableLooking for participantsNCT07667192
What this trial is testing

Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

Who this might be right for
Recurrent Gynecologic CancerRecurrent Uterine CancerRecurrent Cervical Cancer+5 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 500
Testing effectiveness (Phase 2)WithdrawnNCT01613677
What this trial is testing

Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer

Who this might be right for
Treatment for Metastatic or Locally Advanced Cervical Cancer
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT07392060
What this trial is testing

A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment

Who this might be right for
Cervical Cancer Metastatic
Shanghai Jiatan Pharmatech Co., Ltd 440
Not applicableLooking for participantsNCT05914974
What this trial is testing

Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies

Who this might be right for
Gynecological MalignanciesCervical CancerEndometrial Cancer+2 more
University Hospital Tuebingen 120
Early research (Phase 1)Study completedNCT02164461
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Who this might be right for
Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical Adenocarcinoma+6 more
Advaxis, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06859775
What this trial is testing

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 100
Testing effectiveness (Phase 2)WithdrawnNCT05504642
What this trial is testing

Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients

Who this might be right for
Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
Universitätsklinikum Köln
Large-scale testing (Phase 3)Study completedNCT01365156
What this trial is testing

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

Who this might be right for
Cervical Squamous Cell CarcinomaAdenosquamous CarcinomaAdenocarcinoma+2 more
M.D. Anderson Cancer Center 28
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT02257528
What this trial is testing

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Ended earlyNCT05179239
What this trial is testing

SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

Who this might be right for
Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 31
Testing effectiveness (Phase 2)UnknownNCT01667211
What this trial is testing

Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer

Who this might be right for
Uterine Cervical Cancer
Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)Study completedNCT03257267
What this trial is testing

Study of Cemiplimab in Adults With Cervical Cancer

Who this might be right for
Squamous Cell Carcinoma (SCC)Recurrent or Metastatic, Platinum-refractory Cervical Cancer
Regeneron Pharmaceuticals 608